Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
The cancer was caught early and is curable, the executive told staff and shareholders this week.
Anadolu via Getty Images
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news.
Sweet, 57, announced her diagnosis in a staff-wide memo that was followed by an official 8K filing—used to announce significant events to the Securities and Exchange Commission—that alerted shareholders to her situation.
The diagnosis is not all doom and gloom for the executive, who has battled breast cancer before. She told staff, “the prognosis from my doctor is excellent; the cancer was caught early, and my condition is curable.” She added in her 8K filing that the cancer is not present anywhere else in her body.
Fortune was among those praising Sweet’s handling of the matter. The business magazine contrasted her openness—even at this early stage—to how the late Apple CEO Steve Jobs kept his pancreatic cancer diagnosis secret in 2003 and later blamed his weight loss on “hormone imbalance.”
Fortune praised Julie Sweet’s openness about her diagnosis and contrasted it to how the former Apple CEO Steve Jobs (above) kept his pancreatic cancer diagnosis secret.
Justin Sullivan/Getty Images
Jobs’ health secrecy, which included him complaining “curiosity over my personal health continues to be a distraction,” is “no longer acceptable” among top executives in the U.S., Fortune reported. Jobs died in 2011, aged just 56.
Sweet has been the chief executive at Accenture, a global professional services company, since 2019. She reportedly pulled in over $34 million in salary in 2023 and is ranked No. 7 on Forbes’ “The World’s Most Powerful Women” list, trailing mostly world leaders like Mexico’s Claudia Sheinbaum and Italy’s Giorgia Meloni.
Get the best of The Beast delivered right to your inbox
By clicking “SUBSCRIBE” you agree to our Terms of Use and Privacy Policy.
The California native’s memo said she will undergo surgery next week, followed by radiation therapy. She said her doctors estimate her treatment will take three to four months, and she plans to work throughout it.
“I have been advised that I will be able to work substantially as normal, leading the day-to-day operations of the company throughout this process,” she wrote. “I will, however, curtail my travel during this period. The Board has been briefed and is fully supportive.”
See more of our coverage in your search results.
Got a tip? Send it to The Daily Beast here.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.